MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2016-12-16 for LIPOSORBER LA-15 SYSTEM manufactured by Kaneka Corp..
[62678481]
Anaphylactoid reactions with severe hypotension including shock during the ldl-a procedure with liposorber la-15 system are known as one of severe side effects, especially in patients who are concomitantly medicated with ace-inhibitors, which are attributed to the dextran sulfate-cellulose gels (or the ingredient of the "liposorber la-15 ldl adsorption columns"). In japan, patients being treated with any ace-inhibitor is contra-indicated to the ldl-a procedures with this device. It was revealed that the patient had been prescribed with an ace-inhibitor in other hospital, and the physicians conducted the ldl-a on this patient without aware of the fact that the patient was under the influence of an ace-inhibitor. Accordingly, we believe that the event was caused by a use error to apply the device against its contra-indication, and not by any defect or malfunction of the device. The actual device used was not available for our further investigation.
Patient Sequence No: 1, Text Type: N, H10
[62678482]
This incident occurred in (b)(6). The ldl-apheresis (ldl-a) with liposorber la-15 system was applied to a hypercholesterolemic patient with arterio- sclerosis obliterans (aso). The patient developed a shock symptom with a severe hypotension at around 15 minutes after starting the ldl-apheresis. The ldl-a procedure was immediately terminated and the patient's blood pressure was stabilized by administering adrenaline. It was revealed later that the patient had been prescribed in other hospital with ace-inhibitor, that is contra-indicated to this ldla procedure in (b)(6).
Patient Sequence No: 1, Text Type: D, B5
Report Number | 9614654-2016-00020 |
MDR Report Key | 6183190 |
Report Source | FOREIGN,HEALTH PROFESSIONAL |
Date Received | 2016-12-16 |
Date of Report | 2016-09-09 |
Date of Event | 2016-09-08 |
Date Mfgr Received | 2016-09-09 |
Date Added to Maude | 2016-12-16 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Reporter Occupation | OTHER HEALTH CARE PROFESSIONAL |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Manufacturer Contact | MR KAZUHIKO INOUE |
Manufacturer Street | 2-3-18 NAKANOSHIMA, KITA-KU |
Manufacturer City | OSAKA-CITY, OSAKA |
Manufacturer Country | JA |
Manufacturer Phone | 4613072 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 0 |
Brand Name | LIPOSORBER LA-15 SYSTEM |
Generic Name | LIPOPROTEIN, LOW DENSITY, REMOVAL |
Product Code | MMY |
Date Received | 2016-12-16 |
Operator | HEALTH PROFESSIONAL |
Device Availability | N |
Device Age | DA |
Device Eval'ed by Mfgr | R |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | KANEKA CORP. |
Manufacturer Address | 2-3-18 NAKANOSHIMA, KITA-KU OSAKA-CITY 530-8288 JA 530-8288 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Life Threatening | 2016-12-16 |